Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Boston Scientific

(

BSX

) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.3%. By the end of trading, Boston Scientific rose $0.35 (3.6%) to $10.02 on average volume. Throughout the day, 24,885,363 shares of Boston Scientific exchanged hands as compared to its average daily volume of 18,082,500 shares. The stock ranged in a price between $9.64-$10.11 after having opened the day at $9.65 as compared to the previous trading day's close of $9.67. Other companies within the Health Services industry that increased today were:

AdCare Health Systems

(

ADK

), up 6.8%,

Mazor Robotics

(

MZOR

), up 6.5%,

Health Insurance Innovations

(

HIIQ

), up 6.0% and

Trius Therapeutics

(

TSRX

), up 5.9%.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $13.0 billion and is part of the health care sector. Shares are up 68.8% year to date as of the close of trading on Friday. Currently there are 4 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 14 rate it a hold.

TheStreet Ratings rates Boston Scientific as a

sell

. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow and feeble growth in its earnings per share.

On the negative front,

Electromed

(

ELMD

), down 6.3%,

Hooper Holmes

(

HH

), down 6.2%,

USMD Holdings

(

USMD

), down 6.2% and

Organovo Holdings

(

ONVO

), down 5.8% , were all laggards within the health services industry with

Covidien

(

COV

) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care

(

RXD

).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null